Advertisement

Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 600x60px
Document › Details

Roche. (3/19/15). "Press Release: Roche Announces Global Distribution Agreement for Its Biochemical Reagents Product Portfolio with Sigma-Aldrich". Pleasanton, CA.

Region Region ALL
Organisations Organisation Roche Molecular Diagnostics (RMD)
  Group Roche (Group)
  Organisation 2 Sigma-Aldrich Corporation (Nasdaq: SIAL)
  Group Merck (DE) (Group)
Products Product reagents (bio/biochemical)
  Product 2 PCR reagents
Index term Index term Sigma-Aldrich–Roche: biochemical reagents, 201503– distribution ww excl of Roche biochemical reagents portfolio
Persons Person Brown, Paul (Roche 201103 Head Roche Molecular Diagnostics)
  Person 2 Green, Eric (Sigma-Aldrich 200604)
     


Sigma-Aldrich’s supply chain and eCommerce strength will allow broader availability and accessibility of products to customers


Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a global distribution agreement for its Biochemical Reagents product portfolio with Sigma-Aldrich Corporation (NASDAQ: SIAL). These products include kits and enzymes for cellular analysis, proteomics and conventional PCR applications. Under the terms of the agreement, Sigma-Aldrich will acquire exclusive rights for worldwide distribution of these products. Roche remains the legal manufacturer of the products.

“With this agreement, we are able to provide more customers with access to high-quality Roche Biochemical Reagents products through Sigma-Aldrich’s expanded eCommerce and distribution networks,” said Paul Brown, Head of Roche Molecular Diagnostics. “In addition, this will allow us the flexibility to devote more resources in our focus areas.”

"Sigma-Aldrich is excited to offer the global scientific community access to Roche’s leading portfolio of scientific tools and reagents. The addition of these life science tools supports our strategy to augment our portfolio with products that accelerate customer scientific research programs,” said Eric Green, Executive Vice President and President, Sigma-Aldrich Research.“We look forward to working with Roche in this relationship.”

Transition of the Roche portfolio to Sigma-Aldrich is expected to take place in 2015. In the interim, these products will continue to be available through existing Roche channels.

For more information, visit www.lifescience.roche.com or www.sigma-aldrich.com.


About Sigma-Aldrich

Sigma-Aldrich, a leading Life Science and Technology company focused on enhancing human health and safety, manufactures and distributes 250,000 chemicals, biochemicals and other essential products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets. With three distinct business units - Research, Applied and SAFC Commercial - Sigma-Aldrich is committed to enabling science to improve the quality of life. The Company operates in 37 countries, has approximately 9,300 employees worldwide and had sales of $2.79 billion in 2014. For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com.


About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit roche.com.

All trademarks used or mentioned in this release are protected by law.

   
Record changed: 2017-04-02

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download

More documents for Roche (Group)


To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px




» top

Advertisements

Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 22 Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 41 Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px